123 related articles for article (PubMed ID: 30642540)
1. Assessing the lung cancer comorbidome: An analysis of German claims data.
Murawski M; Walter J; Schwarzkopf L
Lung Cancer; 2019 Jan; 127():122-129. PubMed ID: 30642540
[TBL] [Abstract][Full Text] [Related]
2. Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis.
Schwarzkopf L; Witt S; Waelscher J; Polke M; Kreuter M
Respir Res; 2018 Apr; 19(1):73. PubMed ID: 29695236
[TBL] [Abstract][Full Text] [Related]
3. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices.
Yang CC; Fong Y; Lin LC; Que J; Ting WC; Chang CL; Wu HM; Ho CH; Wang JJ; Huang CI
Eur J Cardiothorac Surg; 2018 Jan; 53(1):235-240. PubMed ID: 29106506
[TBL] [Abstract][Full Text] [Related]
4. The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study.
Niksic M; Redondo-Sanchez D; Chang YL; Rodriguez-Barranco M; Exposito-Hernandez J; Marcos-Gragera R; Oliva-Poch E; Bosch-Barrera J; Sanchez MJ; Luque-Fernandez MA
BMC Cancer; 2021 Sep; 21(1):1048. PubMed ID: 34556072
[TBL] [Abstract][Full Text] [Related]
5. Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer.
Mellemgaard A; Lüchtenborg M; Iachina M; Jakobsen E; Green A; Krasnik M; Møller H
J Thorac Oncol; 2015 Feb; 10(2):272-9. PubMed ID: 25371078
[TBL] [Abstract][Full Text] [Related]
6. Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany.
Hernandez D; Cheng CY; Hernandez-Villafuerte K; Schlander M
Oncol Res; 2022; 30(4):173-185. PubMed ID: 37304413
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of comorbidities in COPD patients by disease severity in a German population.
Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
[TBL] [Abstract][Full Text] [Related]
8. Comorbidities in lung cancer: prevalence, severity and links with socioeconomic status and treatment.
Grose D; Morrison DS; Devereux G; Jones R; Sharma D; Selby C; Docherty K; McIntosh D; Louden G; Nicolson M; McMillan DC; Milroy R;
Postgrad Med J; 2014 Jun; 90(1064):305-10. PubMed ID: 24676985
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer.
Gould MK; Munoz-Plaza CE; Hahn EE; Lee JS; Parry C; Shen E
Ann Am Thorac Soc; 2017 Oct; 14(10):1571-1580. PubMed ID: 28541748
[TBL] [Abstract][Full Text] [Related]
10. Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients.
Morishima T; Matsumoto Y; Koeda N; Shimada H; Maruhama T; Matsuki D; Nakata K; Ito Y; Tabuchi T; Miyashiro I
J Epidemiol; 2019 Mar; 29(3):110-115. PubMed ID: 30012908
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity and Survival in Lung Cancer Patients.
Islam KM; Jiang X; Anggondowati T; Lin G; Ganti AK
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1079-85. PubMed ID: 26065838
[TBL] [Abstract][Full Text] [Related]
12. The influence of psychiatric disorders on the course of lung cancer, chronic obstructive pulmonary disease and tuberculosis.
Sikjær MG; Løkke A; Hilberg O
Respir Med; 2018 Feb; 135():35-41. PubMed ID: 29414451
[TBL] [Abstract][Full Text] [Related]
13. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis.
Ludbrook JJ; Truong PT; MacNeil MV; Lesperance M; Webber A; Joe H; Martins H; Lim J
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1321-30. PubMed ID: 12654444
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
Singh N; Singh PS; Aggarwal AN; Behera D
Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
[TBL] [Abstract][Full Text] [Related]
15. The effect of different comorbidities on survival of non-small cells lung cancer patients.
Iachina M; Jakobsen E; Møller H; Lüchtenborg M; Mellemgaard A; Krasnik M; Green A
Lung; 2015 Apr; 193(2):291-7. PubMed ID: 25516286
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity in lung cancer patients and its association with hospital readmission and fatality in China.
Zhu D; Ding R; Ma Y; Chen Z; Shi X; He P
BMC Cancer; 2021 May; 21(1):557. PubMed ID: 34001011
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
18. Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel.
Juan O; Albert A; Campos JM; Caranyana V; Muñoz J; Alberola V
Acta Oncol; 2007; 46(3):367-73. PubMed ID: 17450473
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity in patients undergoing surgery for lung cancer. Do we have an adequate tool to assess it?
Lembicz M; Gabryel P; Brajer-Luftmann B; Dyszkiewicz W; Batura-Gabryel H
Adv Respir Med; 2017; 85(2):55-63. PubMed ID: 28440530
[TBL] [Abstract][Full Text] [Related]
20. Comparing a medical records-based and a claims-based index for measuring comorbidity in patients with lung or colon cancer.
Kehl KL; Lamont EB; McNeil BJ; Bozeman SR; Kelley MJ; Keating NL
J Geriatr Oncol; 2015 May; 6(3):202-10. PubMed ID: 25662785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]